Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Deferred tax assets:
Net operating loss carryforwards	$ 7,927,557	$ 21,713,610
Allowance for credit losses	7,690,645	3,141,395
Equity based compensation	865,427	802,100
Research and experimental expenditures	734,640	412,699
Lease liability	246,043	285,415
Startup costs	7,285	8,339
Accruals	1,668,260	922,553
Nondeductible interest	2,070,071	5,691,795
Other	61,293	60,819
Total net deferred tax assets	21,271,221	33,038,725
Valuation allowance	(3,741,900)	(32,450,807)
Deferred tax liabilities:
Depreciation and amortization	(394,773)	(291,252)
Right-of-use asset	(229,233)	(296,666)
Total net deferred tax liabilities	(624,006)	(587,918)
Net deferred tax asset (liability)	$ 16,905,315	$ 0